The short version of drug affinity complex fits in a sentence. The long version — which is the one that helps — is below.
Reviewed 2025-12-04. Anything still debated is marked as such rather than presented as settled.
Two principal forms appear in the literature and in research supply. One carries a drug affinity complex, a maleimide-based group that forms a covalent bond with circulating albumin. This linkage slows clearance and produces a long-lasting elevation of peptide levels. The other form lacks that group and is often labeled MOD GRF(1-29). It has a much shorter circulation time. Both variants retain the same core receptor-binding sequence. Reported half-lives differ substantially between the two.
At the pituitary, the peptide binds the growth hormone-releasing hormone receptor on somatotroph cells. Receptor activation raises intracellular cyclic AMP and triggers release of stored growth hormone. Somatostatin and other hypothalamic signals modulate this response. Negative feedback from insulin-like growth factor 1 also influences output. The same regulatory architecture operates with the native hormone. Whether the synthetic analog alters feedback dynamics over repeated exposure remains an open question. Most published receptor work uses cell models rather than intact human systems.
CJC-1295 is a synthetic peptide belonging to the growth hormone-releasing hormone analog family. It comprises twenty-nine amino acid residues derived from the N-terminal region of natural GHRH. The molecule incorporates several non-natural substitutions that increase resistance to enzymatic degradation. These modifications extend its activity compared with the native hormone fragment. Researchers use it to study pituitary growth hormone secretion in laboratory and clinical settings. This compound is distinct from native GHRH in its stability profile.
Purity is most often assessed by reversed-phase high-performance liquid chromatography, reported as a percentage of total peak area. Identity is confirmed by mass spectrometry, which yields a molecular ion consistent with the expected sequence. Amino acid analysis and peptide mapping provide additional characterization. Reported purity values are method-dependent, so figures from different laboratories are not always directly comparable without details of column, gradient, and detection wavelength.
Peptide degradation proceeds mainly through hydrolysis, oxidation of methionine, and deamidation of asparagine or glutamine residues. The maleimide group on the albumin-binding variant can also react with thiols or hydrolyze in aqueous media. Because these pathways accelerate with temperature and pH extremes, handling conditions strongly influence measured stability. Stability data in the public literature are limited and often generated under differing conditions, so general statements about shelf life should be read as approximate.
| Property | Value | Notes |
|---|---|---|
| Molecular weight, DAC form | About 3647 Da | Varies with salt form |
| Molecular weight, non-DAC form | About 3358 Da | MOD GRF(1-29) |
| Solubility class | Water soluble | Also dissolves in polar solvents |
| Reported half-life, DAC form | About five to eight days | Values from human studies |
| Common synonyms | CJC-1295; MOD GRF(1-29) | Name depends on variant |
The albumin-binding version stays in circulation for days, because covalent attachment to serum albumin shields the peptide from rapid filtration and degradation. Reported half-lives for this form fall in the range of several days. The version without the linker is cleared in minutes, with estimates often near thirty minutes in animal work. These figures come from small studies and vary with assay method, species, and route, so they are best read as approximate rather than fixed constants.
Studies in this area generally track growth hormone pulses, insulin-like growth factor 1 concentrations, and occasionally body composition endpoints. Most published human data come from early, small trials, and questions about long-term effects remain open. Whether repeated exposure alters pituitary responsiveness over time is not settled. Analytical work relies on immunoassays for the hormones and on mass spectrometry for the peptide itself, because the two measurements answer different questions.
CJC-1295 is a synthetic peptide built as a long-acting analogue of growth hormone-releasing hormone. Its backbone matches the first twenty-nine residues of the natural human hormone, with four amino acid substitutions added to slow enzymatic breakdown. A reactive maleimide group, commonly termed the drug affinity complex, allows the peptide to attach to circulating albumin after administration. That albumin attachment keeps the molecule in the bloodstream for an extended period instead of being cleared within minutes.
The compound emerged from work at a Canadian biotechnology firm in the early 2000s. Early human studies examined its effect on growth hormone and insulin-like growth factor 1 in healthy volunteers and in people with HIV-associated fat redistribution. Reports described sustained increases in both markers after a single injection. Development did not advance to regulatory approval, and the clinical programme was later discontinued. The molecule is now encountered mainly as a research chemical rather than a marketed medicine.
=== Nominal mass === The nominal mass for an element is the mass number of its most abundant naturally occurring stable isotope, and for an ion or molecule, the nominal mass is the sum of the nominal masses of the constituent atoms. Isotope abundances are tabulated by IUPAC: for example carbon has two stable isotopes 12C at 98.9% natural abundance and 13C at 1.1% natural abundance, thus the nominal mass of carbon is 12. The nominal mass is not always the lowest mass number, for example iron has isotopes 54Fe, 56Fe, 57Fe, and 58Fe with abundances 6%, 92%, 2%, and 0.3%, respectively, and a nominal mass of 56 Da. For a molecule, the nominal mass is obtained by summing the nominal masses of the constituent elements, for example water has two hydrogen atoms with nominal mass 1 Da and one oxygen atom with nominal mass 16 Da, therefore the nominal mass of H2O is 18 Da. In mass spectrometry, the difference between the nominal mass and the monoisotopic mass is the mass defect (see § mass defect. This differs from the definition of mass defect used in physics which is the difference between the mass of a composite particle and the sum of the masses of its constituent parts.
=== Other appearances === "TV Eye" with Wylde Ratttz, Velvet Goldmine: Music from the Original Motion Picture, 1999. "Elephant Love Medley" with Nicole Kidman, Moulin Rouge! Music from Baz Luhrmann's Film, 2001. "El Tango de Roxanne" with Jose Feliciano, Moulin Rouge! Music from Baz Luhrmann's Film, 2001. "Your Song" with Alessandro Safina, Moulin Rouge! Music from Baz Luhrmann's Film, 2001. "Here's To Love" with Renée Zellweger, Down With Love: Music from and Included in the Motion Picture, 2003. "The Sweetest Gift", Unexpected Dreams – Songs From the Stars, 2006. "Be Our Guest" with Emma Thompson, Ian McKellen, and Gugu Mbatha-Raw, Beauty and the Beast, 2017. "Days in the Sun" with Adam Mitchell, Stanley Tucci, Ian McKellen, Emma Thompson, Emma Watson, Audra McDonald, Clive Rowe, Beauty and the Beast, 2017. "Something There" with Emma Watson, Dan Stevens, Ian McKellen, Emma Thompson, Nathan Mack, Gugu Mbatha-Raw, Beauty and the Beast, 2017. "The Mob Song", with Luke Evans, Josh Gad, Emma Thompson, Ian McKellen, Stanley Tucci, Nathan Mack, & Gugu Mbatha-Raw, Beauty and the Beast, 2017. "Better Tomorrows", Pinocchio, 2022.
the alternation of late wood and early wood increments within the annual ring; the influence of wood rays on the radial direction; the features of the cell wall structure such as microfibril angle modifications and pits; the chemical composition of the middle lamella. Wood drying may be described as the art of ensuring that gross dimensional changes through shrinkage are confined to the drying process. Ideally, wood is dried to that equilibrium moisture content as will later (in service) be attained by the wood. Thus, further dimensional change will be kept to a minimum. It is probably impossible to completely eliminate dimensional change in wood, but elimination of change in size may be approximated by chemical modification. For example, wood can be treated with chemicals to replace the hydroxyl groups with other hydrophobic functional groups of modifying agents. Among all the existing processes, wood modification with acetic anhydride has been noted for the high anti-shrink or anti-swell efficiency (ASE) attainable without damage to wood. However, acetylation of wood has been slow to be commercialised due to the cost, corrosion and the entrapment of the acetic acid in wood. There is an extensive volume of literature relating to the chemical modification of wood. Drying timber is one method of adding value to sawn products from the primary wood processing industries.
In April 1980, Administrator-General Gerrit Viljoen announced that transfer of some control over military and police forces to South West Africans would occur once the necessary structures were implemented. Through its defence headquarters in Windhoek, the SADF had exercised final authority on all military resources and counter-insurgency efforts. In theory, these arrangements were modified by the establishment of the South West African Territorial Force (SWATF) and the South West African Police (SWAPOL), since both of these forces were placed under the control of the interim government; the latter was also empowered to implement and oversee conscription as it saw fit. However, the SADF retained functional command of all military units; the senior general officer of the SADF in South West Africa also doubled as commander of the SWATF. By the mid 1980s the SWATF numbered about 21,000 personnel and accounted for 61% of all combat troops deployed along the Cutline. Both the SWATF and the Government of National Unity remained dependent on massive SADF military support.
non-canonical amino acid (ncAA) Also non-standard amino acid. Any amino acid, natural or artificial, that is not one of the 20 or 21 proteinogenic amino acids encoded by the standard genetic code. There are hundreds of such amino acids, many of which have biological functions and are specified by alternative codes or incorporated into proteins accidentally by errors in translation. Many of the best known naturally occurring ncAAs occur as intermediates in the metabolic pathways leading to the standard amino acids, while others have been made synthetically in the laboratory.
Sources: en.wikipedia.org
Alpha cells producing glucagon (20% of total islet cells) Beta cells producing insulin and amylin (≈70%) PP cells (gamma cells or F cells) producing pancreatic polypeptide (<5%) Delta cells producing somatostatin (<10%) Epsilon cells producing ghrelin (<1%) It has been recognized that the cytoarchitecture of pancreatic islets differs between species. In particular, while rodent islets are characterized by a predominant proportion of insulin-producing beta cells in the core of the cluster and by scarce alpha, delta and PP cells in the periphery, human islets display alpha and beta cells in close relationship with each other throughout the cluster. The proportion of beta cells in islets varies depending on the species, in humans it is about 40–50%. In addition to endocrine cells, there are stromal cells (fibroblasts), vascular cells (endothelial cells, pericytes), immune cells (granulocytes, lymphocytes, macrophages, dendritic cells,) and neural cells. A large amount of blood flows through the islets, 5–6 mL/min per 1 g of islet. It is up to 15 times more than in exocrine tissue of the pancreas. Islets can influence each other through paracrine and autocrine communication, and beta cells are coupled electrically to six to seven other beta cells, but not to other cell types. Pancreatic islets are characterized by rich innervation and vascularization, although there are notable differences between rodent and human islets. Research indicates that the vascular density in human islets is about five times lower than in rodent islets.
==== Protein C and Protein S ==== Protein C is a major physiological anticoagulant. It is a vitamin K-dependent serine protease enzyme that is activated by thrombin into activated protein C (APC). Protein C is activated in a sequence that starts with Protein C and thrombin binding to a cell surface protein thrombomodulin. Thrombomodulin binds these proteins in such a way that it activates Protein C. The activated form, along with protein S and a phospholipid as cofactors, degrades FVa and FVIIIa. Quantitative or qualitative deficiency of either (protein C or protein S) may lead to thrombophilia (a tendency to develop thrombosis). Impaired action of Protein C (activated Protein C resistance), for example by having the "Leiden" variant of Factor V or high levels of FVIII, also may lead to a thrombotic tendency.
=== Recording of examination === The patient's dentition is divided into six sextants – three sextants for the mandible and maxillary respectively. All teeth, except the 3rd molars, are examined (note the 3rd molars are included if there are no other molars in that sextant). The sextants include: Upper Right (17 to 14) Upper Anterior (13 to 23) Upper Left (24 to 27) Lower Right (47 to 44) Lower Anterior (43 to 33) Lower Left (34 to 37) For a sextant to be recorded, at least two teeth must be present. Otherwise, the lone standing tooth will be included with the recordings of the adjacent sextant.
Abbott expanded the range of stores offering EAS products from niche stores such as GNC to mainstream stores such as Walmart and Target. In March 2011, Abbott laboratories removed the EAS brand from international markets and ceased European production of EAS products. This included the closing of the Canadian and UK country businesses and regional distribution in Europe, Australia, and New Zealand along. In August 2018, the brand was discontinued by Abbott Laboratories.
Sources: en.wikipedia.org
It is a synthetic peptide modeled on growth hormone-releasing hormone. The molecule is used in research on pituitary growth hormone secretion. It differs from the natural hormone through several stabilizing substitutions.
The DAC form carries a maleimide group that binds albumin and extends circulation time. The non-DAC form lacks this group and clears much faster. Both share the same receptor-binding core.
It targets the growth hormone-releasing hormone receptor on pituitary somatotroph cells. Activation raises cyclic AMP and promotes growth hormone release. Normal feedback pathways remain part of the response.
Cool, dark, and dry conditions are standard, with storage at minus twenty degrees Celsius or below. Desiccant and sealed vials limit moisture uptake. Repeated warming and cooling of the container is generally avoided.